Tolerability, Safety, and Efficacy Study of INGAP Peptide to Treat Type 1 Diabetes Mellitus in Adults

NCT00995540 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

23

Enrollment

INDUSTRY

Sponsor class

Stopped Preserve clinical supplies

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: INGAP Peptide
DRUG: INGAP Peptide
DRUG: Placebo

Sponsor

Exsulin Corporation